Results 251 to 260 of about 208,633 (265)

Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors

ESMO Open, 2020
Swaminathan P Iyer, Vivek Subbiah, Sai Ravi Pingali   +2 more
exaly  

Immune Checkpoint Inhibitors: Basics and Challenges

Current Medicinal Chemistry, 2019
Ho Lam Chan, Pingping Chen
exaly  

Management of toxicities of immune checkpoint inhibitors

Cancer Treatment Reviews, 2016
James Larkin, Lavinia Spain, Stefan Diem   +2 more
exaly  

Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors

European Journal of Cancer, 2019
Ralf Gutzmer, Reinhard Dummer
exaly  

Structure and Optimization of Checkpoint Inhibitors

Cancers, 2020
Aaron Hansen, Jeff Doi, Hansen Aaron R
exaly  

Immune checkpoint inhibitors: a narrative review of considerations for the anaesthesiologist

British Journal of Anaesthesia, 2020
Jamie Chaft, Mónica Girotra, Gregory W Fischer   +2 more
exaly  

Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy

Seminars in Cancer Biology, 2019
Enrica TERESA Tanda, Andrea Boutros, Paola Queirolo   +2 more
exaly  

Hypophysitis induced by immune checkpoint inhibitors: a 10-year assessment

Expert Review of Endocrinology and Metabolism, 2019
Patrizio Caturegli, Giulia Di Dalmazi, Silvia Ippolito   +2 more
exaly  

Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer

Annals of Oncology, 2018
Derosa Lisa, K C Arbour, H Rizvi
exaly  

Bispecific checkpoint inhibitor antibodies

2022
BERNETT MATTHEW, MOORE GREGORY, DESJARLAIS JOHN, HEDVAT MICHAEL, BONZON CHRISTINE, NISTHAL ALEX, MUCHHAL UMESH S   +6 more
openaire   +4 more sources